Early metformin use after infection might decrease long COVID risk
Emerging research suggests that starting metformin soon after a COVID-19 infection could lower the likelihood of developing long COVID, offering a potential preventive approach for at-risk individuals. This discovery may open new avenues for early intervention, aiming to reduce prolonged symptoms that affect millions worldwide.Long COVID, characterized by lingering fatigue, brain fog, shortness of breath, and other persistent symptoms, has become a major public health concern. While vaccines and antiviral treatments have helped reduce severe illness and hospitalization, they do not always prevent post-viral complications. Metformin, a well-known medication commonly prescribed for type 2 diabetes, has recently gained attention for…
